Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Hafnia
HAFN
$3.8B
| $1.14M | ﹤0.01% |
229,107
-274,978
| -55% | -$1.34M |
|
3202
MGP Ingredients
MGPI
$381M
| $1.14M | ﹤0.01% |
38,136
+13,773
| +57% | +$410K |
|
3203
OneSpan
OSPN
$609M
| $1.14M | ﹤0.01% |
68,301
+18,856
| +38% | +$293K |
|
3204
PACS Group
PACS
$7.2B
| $1.14M | ﹤0.01% |
88,131
+35,762
| +68% | +$372K |
|
|
DFTX
3205
Definium Therapeutics
DFTX
$5.9B
| $1.14M | ﹤0.01% |
175,233
+55,660
| +47% | +$366K |
|
3206
PUT
Align Technology
ALGN
$12.4B
| $1.14M | ﹤0.01% |
+6,000
| New | +$1.06M |
|
3207
Republic Bancorp
RBCAA
$1.91B
| $1.14M | ﹤0.01% |
15,536
+5,197
| +50% | +$355K |
|
3208
Alerus Financial
ALRS
$843M
| $1.13M | ﹤0.01% |
52,429
+15,347
| +41% | +$307K |
|
|
KDK
3209
Kodiak AI
KDK
$821M
| $1.13M | ﹤0.01% |
+100,000
| New | +$1.13M |
|
3210
Orange County Bancorp
OBT
$522M
| $1.13M | ﹤0.01% |
43,845
+21,196
| +94% | +$517K |
|
3211
FS Bancorp
FSBW
$325M
| $1.13M | ﹤0.01% |
28,731
+3,665
| +15% | +$142K |
|
3212
Atour Lifestyle Holdings
ATAT
$4.6B
| $1.13M | ﹤0.01% |
34,784
-118,712
| -77% | -$3.37M |
|
3213
CALL
Keysight
KEYS
$60.6B
| $1.13M | ﹤0.01% |
+6,900
| New | +$1.05M |
|
3214
Altimmune
ALT
$560M
| $1.13M | ﹤0.01% |
292,095
+104,633
| +56% | +$566K |
|
3215
PUT
LivaNova
LIVN
$4.53B
| $1.13M | ﹤0.01% |
25,100
| – | – |
|
|
MRP
3216
Millrose Properties Inc
MRP
$5.02B
| $1.13M | ﹤0.01% |
39,579
+5,740
| +17% | +$152K |
|
3217
GigaCloud Technology
GCT
$1.9B
| $1.13M | ﹤0.01% |
57,027
+18,024
| +46% | +$288K |
|
|
LKFT
3218
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $1.12M | ﹤0.01% |
40,169
+8,309
| +26% | +$223K |
|
|
INVX
3219
Innovex International
INVX
$2.15B
| $1.12M | ﹤0.01% |
71,945
+26,715
| +59% | +$411K |
|
3220
Rigel Pharmaceuticals
RIGL
$762M
| $1.12M | ﹤0.01% |
59,806
+30,595
| +105% | +$580K |
|
3221
American Outdoor Brands
AOUT
$159M
| $1.12M | ﹤0.01% |
107,134
+107,022
| +95,555% | +$1.22M |
|
3222
Malibu Boats
MBUU
$576M
| $1.12M | ﹤0.01% |
35,676
+3,459
| +11% | +$104K |
|
|
RPC
3223
Ridgepost Capital
RPC
$972M
| $1.12M | ﹤0.01% |
109,396
+53,146
| +94% | +$569K |
|
3224
Bank of Marin Bancorp
BMRC
$462M
| $1.12M | ﹤0.01% |
48,884
+8,499
| +21% | +$181K |
|
3225
Daily Journal
DJCO
$828M
| $1.11M | ﹤0.01% |
2,635
+887
| +51% | +$354K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.